Mania News and Research

RSS

Bipolar disorder costs twice as much in lost productivity as major depressive disorder

Bipolar disorder costs twice as much in lost productivity as major depressive disorder, a study funded by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) has found. Each U.S. worker with bipolar disorder averaged 65.5 lost workdays in a year, compared to 27.2 for major depression.

4 Sep 2006

ADHD drugs to carry warnings regarding heart problems, psychotic behavior and sudden death

According to U.S. health officials several drugs used to treat attention deficit hyperactivity disorder (ADHD) must now include new warning information about the risk of serious heart problems, psychotic behavior and sudden death.

24 Aug 2006

Antipsychotic use in children increasing

A steadily increasing number of patients younger than age 20 received prescriptions for antipsychotic medications between 1993 and 2002, according to a report published in the June issue of Archives of General Psychiatry.

9 Jun 2006

Bipolar disorder causes children to misinterpret facial expressions

Researchers at the National Institute of Mental Health (NIMH) have discovered why children with bipolar disorder tend to be more aggressive and irritable and have poorer social skills than healthy children.

31 May 2006

New tool identifies those at risk of bipolar disorder

According to a new study researchers have identified five predictors for bipolar disorder risk in patients who have been unsuccessfully treated with antidepressants.

23 May 2006

ADHD drug not safe for kids

According to a panel of experts advising the U.S. Food and Drug Administration (FDA), the drug Provigil, although effective in treating attention deficit hyperactivity disorder (ADHD) in children and teenagers, is not safe enough to win approval.

26 Mar 2006

Mood-swings impair attention and memory

A review on the neuropsychological aspects of bipolar disorder (alternations of mania and depression) by the group of Eduard Vieta (University of Barcelona) points to impairments in intellectual functioning in this patient population.

13 Mar 2006

Repligen commences phase 2 trial of RG2417 for bipolar depression

Repligen Corporation today announced that the Company has initiated a Phase 2 clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.

9 Mar 2006

Children and teen-agers with bipolar disorder suffer from the illness differently than adults do

Their symptoms last longer and swing more swiftly from hyperactivity and recklessness to lethargy and depression.

17 Feb 2006

Bipolar disorder in children

Children with bipolar disorder experience more enduring and rapidly changing symptoms of the disease than adults, according to a study that, for the first time, maps the clinical progression of each of the three sub-types of bipolar disorder in children and adolescents.

9 Feb 2006

Identification of bipolar risk gene

A collaboration, led by scientists at the Garvan Institute of Medical Research and the University of New South Wales (UNSW) in Sydney, has discovered the first risk gene specifically for bipolar disorder, also known as manic-depressive illness. This means that people who have a particular form of this gene are twice as likely to develop the disease.

16 Jan 2006

Bipolar disorder more common in teenage psychiatric patients

Clinicians at Bradley Hospital, the nation's first psychiatric hospital for children and adolescents, have found that bipolar disorder is more common than expected in teens in a psychiatric inpatient setting.

29 Dec 2005

Positive aspects of bipolar disorder

Researchers at the Stanford University School of Medicine have shown for the first time that a sample of children who either have or are at high risk for bipolar disorder score higher on a creativity index than healthy children.

14 Nov 2005

Mental health professionals need to be watchful of mental health problems beyond depression in order to prevent youth suicide

WHO researchers examine which mental disorders or combinations of disorders may be most responsible for youth suicide in a new study being released in the October issue of the American Journal of Orthopsychiatry, published by the American Psychological Association (APA).

23 Oct 2005

Link between emotional impairment and poor cognition in children with bipolar disorder

Using functional magnetic resonance imaging, Pavuluri and her colleagues examined the brain activity of teens while they were performing certain mental tasks. The researchers scanned the brains of 10 unmedicated bipolar patients with normal mood and compared them with 10 healthy subjects of the same age and gender.

20 Oct 2005

Manic depression linked to two chromosomal regions in the human genome

An international team of 53 researchers has offered the most convincing evidence so far linking bipolar disorder, also known as manic depression, to two chromosomal regions in the human genome. The finding gives scientists refined targets for further gene studies.

19 Sep 2005

Interpersonal and social rhythm therapy is helpful to many people with bipolar disorder

A treatment program that stresses maintaining a regular schedule of daily activities and stability in personal relationships is an effective therapy for bipolar disorder, report University of Pittsburgh School of Medicine researchers in September's Archives of General Psychiatry.

12 Sep 2005

Bipolar survey indicates how patient satisfaction is achieved

Preliminary results from a large-scale global study of people living with bipolar disorder, presented today at the World Congress of Biological Psychiatry (WCBP), found that patient satisfaction with treatment is achieved through combining broad-based efficacy with a favourable tolerability profile.

30 Jun 2005

Brain differences in bipolar disorder shown in MRI

Experts in the U.S., in an attempt to define the abnormalities in the brains of people with bipolar disorder, have used used functional MRI to measure levels of metabolic activity in different areas of the brain.

21 Jun 2005

Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia

A new study, published in the journal Human Psychopharmacology: Clinical and Experimental, shows that the atypical antipsychotic Seroquel (quetiapine), may be an effective treatment option for patients with schizophrenia who exhibit aggressive behaviour during psychotic episodes.

19 Jun 2005